a b c d e f g h i j k l m n o p q r s t u v w x y z #

Plasma Products Lot Release Certificates

 

PROTHROMBINEX-VF 3280920500

  • Date of Issuance: 4-Apr-19

PROTHROMBINEX-VF 3280920524

  • Date of Issuance: 1-Jul-19

Prothrombinex_VF 3280920426

  • Date of Issuance: 16-Nov-17

Prothrombinex_VF 3280920430

  • Date of Issuance: 16-Nov-17

Prothrombinex_VF 3280920438

  • Date of Issuance: 16-Nov-17

Replenine VF (High Purity Factor IX) FJS15171

  • Date of Issuance: 16-Aug-2016

Replenine VF (High Purity Factor IX) FJS15171

  • Date of Issuance: 19-Dec-16

Rhesonativ 625 IU/mL solution for injection M650A870A

  • Date of Issuance: 22-Feb-17

Rhesonativ 625 IU/mL solution for injection M802A8702

  • Date of Issuance: 16-Apr-18

Rhesonativ 625 IU/mL Solution for Injection M813A8703

  • Date of Issuance: 9-Jul-18

RHESONATIV 625 IU/ML SOLUTION FOR INJECTION M814A870E

  • Date of Issuance: 13-Aug-18

RHESONATIV 625 IU/ML SOLUTION FOR INJECTION M848A8703

  • Date of Issuance: 9-Apr-19

RHESONATIV 625 IU/ML SOLUTION FOR INJECTION M907A8703

  • Date of Issuance: 13-May-19

RHESONATIV 625 IU/ML SOLUTION FOR INJECTION M907A8703 (2)

  • Date of Issuance: 24-Jun-19

RHESONATIV 625 IU/ML SOLUTION FOR INJECTION M921A870C

  • Date of Issuance: 4-Sep-19
<<  29 30 31 32 33 [3435 36 37 38  >>  

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Monday 20 January 2020, 13:55:33.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language